Please ensure Javascript is enabled for purposes of website accessibility
Home / Business / FTC opens probe into sales-delay agreements between drug companies

FTC opens probe into sales-delay agreements between drug companies

U.S. regulators, armed with a year-old Supreme Court decision, are stepping up investigations of pharmaceutical deals that delay the sale of generic drugs, arrangements they view as illegally hurting competition.

Leave a Reply

Your email address will not be published. Required fields are marked *

*